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ADAM10 and ADAM17 are two closely related members of the ADAM (a disintegrin and
metalloprotease) family of membrane-bound sheddases, which proteolytically cleave surface membrane proteins. Both ADAM10 and ADAM17 have been implicated in the proteolytic cleavage of NOTCH receptors and as such regulators of NOTCH signaling. During
retinal development, NOTCH signaling facilitates retinal neurogenesis by maintaining progenitor cells in a proliferative state and by mediating retinal cell fates. However, the roles of
ADAM10 and ADAM17 in the retina are not well defined. In this study, we set out to clarify
the roles of ADAM10 and ADAM17 during early retinal development. The retinal phenotype
of conditionally abated Adam17 retinae (Adam17 CKO) did not differ from the controls
whereas conditionally ablated Adam10 retinae (Adam10 CKO) exhibited abnormal morphogenesis characterized by the formation of rosettes and a loss of retinal laminae phenotypically similar to morphological abnormalities identified in mice with retinal NOTCH signaling
deficiency. Additionally, Adam10 CKO retinae exhibited abnormal neurogenesis characterized by fewer proliferating progenitor cells and greater differentiation of early photoreceptors
and retinal ganglion cells. Moreover, constitutive activation of the NOTCH1-intracellular
domain (N1-ICD) rescued Adam10 CKO abnormal neurogenesis, as well as abnormal retinal morphology by maintaining retinal cells in the progenitor state. Collectively these findings provide in vivo genetic evidence that ADAM10, and not ADAM17, is indispensable for
proper retinal development as a regulator of NOTCH signaling.

Introduction
During retinal development, all retinal cell types are derived from a single population of pluripotent retinal progenitor cells (RPCs). The birth order of retinal cells is unidirectional and highly
conserved although at any given developmental time point there is an overlap in the generation
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of various retinal cell types [1–3]. In mice, retinal neurogenesis starts around E11 with the
birth of ganglion cells followed by the birth of cone photoreceptors, horizontal and amacrine
cells, with rod photoreceptors forming around birth and finally bipolar cells and Müller glia as
the last retinal cell types born postnatally [1–3]. It has been proposed that RPCs undergo temporally regulated successive stages of competence to either generate a differentiated retinal cell
type or to transit to the next stage of RPC competence that facilitates the birth of subsequent
retinal cell types [1, 3].
NOTCH signaling is an evolutionarily conserved pathway involved in the development of
most tissues. The role of NOTCH signaling is in the regulation of cell proliferation, cell death,
cell fate determination, and differentiation [4, 5]. In mammals, there are four NOTCH receptors (NOTCH1-4) and five NOTCH ligands (JAG1, JAG2, DLL1, DLL3, DLL4) that exhibit
both redundant and unique functions [4]. The canonical NOTCH pathway involves binding of
a NOTCH ligand from the surface of adjacent cells to the NOTCH receptor thereby facilitating
the subsequent NOTCH receptor cleavage at the S2 site followed by cleavage at the S3 and S4
sites resulting in the release of the NOTCH intracellular domain (NICD) from the cell membranes; once released the NICD translocates into the nucleus and forms a complex with RBPJ
and MAML1 along with other cofactors to transcriptionally activate inhibitors of differentiation [6–8]. Therefore, one of the key roles of NOTCH signaling is maintaining progenitor cells
in their undifferentiated state. Additionally, during retinal development NOTCH signaling
facilitates neurogenesis by repressing retinal cell fates [9–15].
ADAM10 and ADAM17 are two closely related members of the ADAM family of proteins
that proteolytically cleave or “shed” ectodomains of cell surface proteins [16, 17]. Both
ADAM10 and ADAM17 have been implicated as sheddases of NOTCH receptors at the S2
cleavage site thereby facilitating subsequent cleavage at S3 and S4 sites by the γ-secretase complex [18–21]. In C. elegans, sup-17, the ortholog of ADAM10, and adm-4, the ortholog of
ADAM17, are functionally redundant as NOTCH regulators [21]. In Drosophila, Kuzbanian
(kuz), the fly ortholog of ADAM10, regulates NOTCH cleavage and signaling [18–20]. Phenotypically, kuz mutants exhibit neurogenic and ommatidial defects similar to those observed in
the fly Notch mutants [18]. Mice deficient for Adam10 die at E9.5 and phenocopy Notch1 deficient mice [22] in contrast to Adam17-/- mice that die at birth without phenotypic similarities
to Notch1 mouse mutants [23, 24]. Although findings from knock-out mice implicate
ADAM10 in the proteolytic cleavage of NOTCH1, tissue culture studies have shown that
ADAM17, and not ADAM10, cleaves NOTCH1 [25, 26]. Further studies determined that
ADAM10 is indispensable for ligand-induced NOTCH1 signaling and ADAM17 mediates
ligand-independent NOTCH1 cleavage [27, 28]. Therefore, it was proposed that different
ADAMs might contribute to the NOTCH receptor cleavage in a tissue-specific manner with
ADAM10 as the primary regulator of NOTCH1 cleavage in vivo [22]. Recent studies support
this hypothesis showing that in vivo ADAM10 regulates NOTCH1 during brain [29], skin [30],
intestinal [31], thymocyte [32], and vascular development [33].
During retinal development, the roles of ADAM10 and ADAM17 are unclear. Both
ADAM10 and ADAM17 exhibit similar spatiotemporal expression in the developing chicken
retina [34]. The early embryonic lethality of Adam10-/- mice prior to the optic cup formation
has precluded any evaluation of the role of ADAM10 in the retina [22]. However, pharmacological inhibition of ADAM10 partially rescued upregulated NOTCH1 signaling in mouse retinae deficient for Srfp1 and Srfp2 implicating ADAM10 as a regulator of NOTCH1 signaling
during early retinal development [35]. By contrast, at birth Adam17-/- mice do not exhibit any
obvious retinal abnormalities suggesting that ADAM17 does not have an essential role during
the early retinal development, although the perinatal death of Adam17-/- mice precluded evaluations of the postnatal Adam17 deficient mature retinae [23, 24].
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The goal of this study was to determine the roles of ADAM10 and ADAM17 in the retina
and establish whether ADAM10, ADAM17, or both regulate retinal NOTCH1 signaling. Our
results demonstrate that ADAM10, and not ADAM17, is indispensable for early retinal development as a key regulator of NOTCH1 signaling.

Materials and Methods
Mice and clinical eye evaluation
All animal procedures were performed in accordance with NIH guidelines and approved by
the Medical College of Wisconsin Institutional Animal Care and Use Committee (IACUC).
Mice carrying a floxed Adam10 allele (Adam10tm1.1Zhu) were generously provided by Tian Xu.
Mice carrying a floxed Adam17 allele (Adam17tm1.2Bbl), were generously provided by Carl Blobel. Six3-Cre mice carrying a Cre allele driven by the promoter of the Six3 gene were generously
provided by Yasuhide Furuta. Gt(ROSA)26Sor tm1(NOTCH1)Dam/J. Each mouse strain was genotyped as previously described [24, 32, 36, 37] using primers in S1 Table. Mice with Six3-Cre;
Adam10tm1Zh/tm1Zhu or Six3-Cre; Adam17tm1Bbl/tm1Bbl genotypes were referred to here as
Adam10 CKO mice and Adam17 CKO mice respectively. Littermates with genotypes
Adam10tm1Zhu/+ and Adam10tm1Zhu/ tm1Zhu as well as Adam17tm1Bbl/+ and Adam17tm1Bbl/tm1Bbl
are referred to as controls.
Mouse eyes from the eight week old control, Adam10 CKO, and Adam17 CKO mice were
examined with a Topcon SL-D8Z slit lamp biomicroscope with a Nikon SLR-based Photo Slit
Lamp imaging system following mydriasis with 1% atropine sulfate (Bausch & Lomb) as previously described [38]. Control (n = 3) and Adam17 CKO (n = 3) animals at 8 weeks of age were
dark adapted for 2 hr and ERGs were recoded after a single flash of intensity sufficient to evoke
the maximum retinal response as previously described [39].

RT-PCR
Eyes from newborn mice (n = 3) of each genotype were collected and the cornea, iris, and lens
were removed. RNA was isolated and reverse transcribed as previously described [40]. Adam10
or Adam17 transcript levels were analyzed via semi-quantitative RT-PCR while in the exponential phase of the PCR amplification using Gapdh as an internal control as previously
described [40] using primers in S1 Table. PCR band intensities were quantified using ImageJ
software (http://rsbweb.nih.gov/ij/) and are expressed relative to Gapdh. The results represent
at least three independent experiments performed in triplicates and the data is expressed as
mean ± SEM. Comparison between the genotype groups was analyzed by Student’s t-test and
P<0.05 was considered as statistically significant.

Histology and immunohistochemistry
Tissues were fixed in 4% PFA, or Davidson’s solution, embedded in paraffin, sectioned to 4 μm
thickness and Hematoxylin and Eosin (H&E) stained as previously described [38]. For immunohistochemistry, following deparaffinization and rehydration, antigen retrieval was performed using 1x citrate buffer pH 6.0 (Life Technologies) as previously described [38] and then
sections were blocked in 10% normal serum with 1% BSA in 1xPBS for 1–2 hr and incubated
with primary antibody in 1xPBS with 1% BSA O/N at 4°C. 2x 5 min washes in 1xPBS, 0.025%
Triton X-100 were followed by secondary antibody incubation in 1xPBS with 1% BSA for 1 hr
at RT. Primary antibodies used in this study include: ADAM10 (R&D Systems), BRN3B,
ADAM17 OTX2, and N-cadherin (Abcam), ISL1 (Hybridoma Bank), β-catenin, NOTCH1 and
HES1 (Cell Signaling). Secondary antibodies used were Alexa Fluor 546 goat-anti rabbit and
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Alexa Fluor 488 goat-anti mouse (Life Technologies). All slides were counterstained with
DAPI (Life Technologies), mounted using Prolong gold anti-fade reagent (Life Technologies)
mounting media, and photographed with a Nikon DS-Fi1 camera on a Nikon eclipse 80i
microscope. The percentage of OTX2 and ISL1positive cells were determined by counting the
numbers of OTX2 and ISL1 positive cells and total DAPI positive cells from a minimum of 3
separate genotypes with at least 10 sections per genotype. Significance was calculated via Students t-test (GraphPad Prism), and P<0.05 was considered significant.

EdU, BrdU, and TUNEL assays
EdU (Life Technologies) or BrdU was injected intraperitoneally at a dose of 125 mg/kg of body
weight into pregnant dams, 13.5 days after a vaginal plug was found and sacrificed 2 hr later.
Embryos were fixed in 4% PFA for 2 hours and dehydrated through a graded series of ethanol
washes, were paraffin embedded, and cut into 5 μm sections. EdU detection was performed
with Click-iT EdU Alexa Fluor 488 Imaging Kit (Life Technologies) according to the manufacturer’s protocol and BrdU was detected using a mouse monoclonal anti-BrdU antibody conjugated to Alexa Flour 488 (Life Technologies). TUNEL staining was performed utilizing the
ApopTag Plus In Situ Apoptosis Fluorescein Detection Kit (Millipore) according to the manufacturer’s recommendations. DAPI (Life Technologies) was used to stain the DNA, slides were
mounted using Prolong gold anti-fade reagent (Life Technologies) and imaged using a Nikon
DS-Fi1 camera on a Nikon Eclipse 80i microscope. The percentage of EdU, BrdU, and TUNEL
positive cells after counting the numbers of EdU, BrdU or TUNEL positive cells and total
DAPI positive cells from a minimum of 3 separate genotypes with at least 10 sections per genotype. Significance was calculated via a t-test (GraphPad Prism) and P<0.05 was considered
significant.

Results
ADAM10 and ADAM17 are ubiquitously expressed retinal proteins
As the initial step, we evaluated the expression of ADAM10 and ADAM17 during retinal development in mice. In control embryonic E13.5, E16.5 and newborn P0.5 retinae both ADAM10
(Fig 1A, 1C and 1E) and ADAM17 (Fig 1B, 1D and 1F) exhibit ubiquitous expression in ganglion cell and neuroblastic layers. By P7, as the retina starts to mature, ADAM10 and
ADAM17 are expressed in the ganglion cell layer, inner and outer plexiform layers, and in the
photoreceptors (Fig 1G and 1H) and this pattern of expression is maintained in the adult retina
for both ADAM10 (Fig 1I) and ADAM17 (Fig 1J).

ADAM10, but not ADAM17, is required for early retinal development
To determine the roles of ADAM10 and ADAM17 during early retinal development, we generated mice with retina-specific ablation of Adam10 (Adam10 CKO), as well as retina-specific
ablation of Adam17 (Adam17 CKO) (Fig 2A and 2B). In newborn Adam10 CKO and Adam17
CKO retinae, only residual levels of Adam10 transcript containing exon 3 (Fig 2C) and
Adam17 transcript containing exon 2 (Fig 2D) were identified when compared to the controls.
Therefore, Adam10 and Adam17 were successfully disrupted in most retinal cells in Adam10
CKO and Adam17 CKO mice respectively.
The evaluation of adult (8 weeks of age) Adam10 CKO eyes by observation revealed a
smaller eye size (Fig 2F) when compared to age-matched control littermates (Fig 2E). Adam17
CKO mice did not exhibit any obvious eye size differences (Fig 2H) when compared to agematched control littermates (Fig 2G). Histological analysis of adult Adam10 CKO eyes
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Fig 1. Expression of ADAM10 and ADAM17 in the retina. Immunostaining of control E13.5 retinae for
ADAM10 (A) and ADAM17 (B), E16.5 retinae for ADAM10 (C) and ADAM17 (D) and P0.5 retinae for
ADAM10 (E) and ADAM17 (F) revealed similar expression patterns in the ganglion cell layer (GCL) and
neuroblastic layer (NBL). Immunostaining of P7 retinae for ADAM10 (G) and ADAM17 (H) and P28 retinae for
ADAM10 (I) and ADAM17 (J) also revealed similar expression patterns in the inner plexiform layer (IPL),
outer plexiform layer (OPL) and in the photoreceptors. INL = inner nuclear layer; ONL = outer nuclear layer.
Nuclei were stained with DAPI. Scale bars = 50 μm.
doi:10.1371/journal.pone.0156184.g001

identified profoundly disrupted retinal laminae (Fig 2J and S1B Fig) characterized by the formation of rosettes (Fig 2J’). Histological analysis of Adam17 CKO eyes and retinae (Fig 2L and
2L’ and S1D Fig) did not identify any morphological differences when compared to agematched control littermates (Fig 2K and 2K’ and S1C Fig). To exclude the possibility that
Adam17 CKO retinae may exhibit functional, but not morphological abnormalities we performed electroretinograms (ERGs). Our analysis did not identify any differences in ERGs
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Fig 2. Conditional ablation of Adam10 and Adam17 in the retina. (A) Mice carrying homozygous floxed Adam10 allele
(Adam10tm1.1Zhu) were crossed with Six3-Cre transgenic mice expressing Cre in the optic cup and optic stalk resulting in
conditionally ablated Adam10 in the retina. (B) A similar approach was taken to generate Adam17 CKO mice after
homozygote Adam17tm1.2Bbl mice were crossed to Six3-Cre mice. (C) Semi-quantitative analysis of the relative expression
of Adam10 transcript containing exon 3 normalized to Gapdh expression from RNA isolated from newborn control and
Adam10 CKO littermates revealed significantly reduced (P<0.0001; n = 3) levels in Adam10 CKO retinae when compared to
the controls. (D) Semi-quantitative analysis of the relative expression of exon 2 containing Adam17 mRNA normalized to
Gapdh expression from RNA isolated from newborn control and Adam17 CKO retinae also revealed significantly reduced
(P<0.0002; n = 3) levels in Adam17 CKO retinae when compared to the controls. In both (C) and (D), the bars represent
mean values ± SEM. Significance was established following Student’s t-test analysis and P<0.05 was considered
significant. (F) Adam10 CKO eyes appeared smaller when compared to the eyes in the control mice (E) whereas Adam17
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CKO eyes (H) that did not appear to differ from age-matched control littermates (G). H&E staining of Adam10 CKO eyes at 8
weeks of age (J) revealed severe retinal abnormalities characterized by the formation of rosettes (J’, arrow) in contrast to the
retinal laminae in the age-matched controls (I-I’). Histological analysis of Adam17 CKO eyes (L-L’) did not identify any
morphological differences when compared to the age-matched controls (K-K’). Figures shown in (I’) through (L’) are
enlarged images of the areas depicted by the dashed boxes in Figures (I) through (L). GCL = ganglion cell layer, IPL = inner
plexiform layer, INL = inner nuclear layer, OPL = outer plexiform layer, ONL = outer nuclear layer. Scale bars = 50 μm.
doi:10.1371/journal.pone.0156184.g002

between the control and Adam17 CKO mice (not shown). Collectively these findings provided
evidence that ADAM10, and not ADAM17, is required for early retinal development.

The onset and progression of retinal phenotypes in Adam10 CKO mice
The first morphological abnormalities in Adam10 CKO retinae were evident at E13.5 characterized by disrupted cellular architecture (Fig 3B). Along the apical-basal axis nuclei from
Adam10 CKO retinae appeared rounded and disorganized resulting in misshapen apical and
basal surfaces (Fig 3B’). By contrast, the E13.5 control retinae exhibited elongated and organized nuclei with distinct apical and basal surfaces (Fig 3A and 3A’). While morphological
abnormalities were identified within the Adam10 CKO central retinae some regions of peripheral retinae retained undisrupted retinal cell organization (Fig 3B). It was reported previously
that Six3-Cre is expressed across the entire retina although the highest expression is within the
central retina [36]. To explore this further, we immunostained the control and the Adam10
CKO retinae for ADAM10. Within the central Adam10 CKO retinae, the majority of cells did
not express ADAM10 (Fig 3D and S2B Fig). However, at the retinal periphery, we identified
residual ADAM10 immunostaining (Fig 3D and S2B Fig). This finding suggested that milder
retinal abnormalities identified at the retinal periphery of E13.5 Adam10 CKO may have been
caused by the lower efficiency of CRE-mediated Adam10 ablation relative to the central retina.
By E16.5 the Adam10 CKO retinae started to exhibit rosettes within the central retinae (Fig
3F); the identified rosettes were of different sizes (Fig 3F’). Immunostaining of E16.5 Adam10
CKO retinae for ADAM10 did not identify any residual staining (Fig 3H). We also morphologically evaluated the postnatal retinal development of Adam10 CKO mice. By P0.5 in Adam10
CKO retinae, the formation of rosettes expanded further towards the retinal periphery (S2D
and S2D’ Fig) and by P7 the rosettes were present throughout the entire retina (S2F and S2F’
Fig).

ADAM10 inactivation disrupts retinal neurogenesis
Next, we wanted to determine if Adam10 CKO retinae exhibited disrupted neurogenesis. At
E13.5 in control retinae, EdU-positive cells were highly organized and restricted to the neuroblastic layer (Fig 4A) whereas in E13.5 Adam10 CKO retinae EdU-positive cells were highly
disorganized (Fig 4B). Quantification analysis revealed a significantly lower (P = 0.019; n = 3)
percentage of EdU-positive cells in the Adam10 CKO retinae when compared to the controls
(Fig 4C). Next, we hypothesized that the fewer proliferating cells identified in Adam10 CKO
retinae (Fig 4A–4C) may be caused by precocious retinal cell differentiation. Immunostaining
of the control retinae for orthodenticle homeobox 2 (OTX2), which is a marker for early photoreceptors [41], revealed sparse OTX2-positive staining in cells along the retinal apical surface
consistent with the development of early photoreceptors (Fig 4D). By contrast, Adam10 CKO
retinae exhibited highly disorganized OTX2-positive cells (Fig 4E). Quantification analysis
revealed a significantly greater (P = 0.003; n = 3) percentage of OTX2-positive cells in the
Adam10 CKO retinae when compared to the controls (Fig 4F). We also evaluated the ISL1
expression as a marker for early ganglion cells [42]. In control retinae, ISL1 immunostaining
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Fig 3. Retinal morphology in control and Adam10 CKO mice. H&E staining revealed first abnormalities in
E13.5 Adam10 CKO retinae (B) within the central region characterized by rounded and highly disorganized
nuclei along the apical-basal axis resulting in disrupted basal and apical surfaces (B’, arrows) in contrast to
the highly organized control retinae (A-A’). ADAM10 immunostaining of E13.5 Adam10 CKO retinae (D,
arrowhead) revealed an absence of ADAM10 expressions in most cells within the central retina when
compared to the age-matched controls (C). However, residual ADAM10 expression was detected in the
peripheral retinae of Adam10 CKO mice (D, arrows). H&E staining of E16.5 Adam10 CKO retinae (F)
identified within the central region rosettes of various sizes (F’) in contrast to the highly organized retinal
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laminae in the age-matched control retinae (E-E’). Immunostaining of E16.5 Adam10 CKO retinae (H) did not
identify any ADAM10-positive cells in contrast to the age-matched controls (G). BA = basal surface,
AP = apical surface. Scale bars = 50 μm.
doi:10.1371/journal.pone.0156184.g003

was restricted to the cells at the retinal basal layer consistent with the developing ganglion cells
(Fig 4G). In the Adam10 CKO retinae, ISL1-positive cells were highly disorganized (Fig 4H).
Quantification analysis revealed a significantly greater (P = 0.004; n = 3) percentage of ISL1-positive cells in E13.5 Adam10 CKO when compared to the control retinae (Fig 4I). Similar
findings were observed following immunostaining with BRN3B (S3A–S3C Fig), a marker for
early ganglion cells [42]. In both the control (Fig 4J) and Adam10 CKO retinae (Fig 4K), the
OTX2-positive and ISL1-positive cells did not co-stain for EdU, indicating that OTX2-positive
and ISL1-positive cells had exited the cell cycle.

Characterization of rosettes in E16.5 Adam10 CKO retinae
Morphological evaluation of Adam10 CKO retinae revealed the formation of rosettes at E16.5
(Fig 3F and 3F’). Next we set to characterize which cells formed the rosettes in E16.5 Adam10
CKO retinae. In the control, the retinae BrdU-positive cells are positioned between the OTX2positive photoreceptors on the apical side and ISL1-positive ganglion cells at the basal side (Fig
5A and 5C). Immunostaining of Adam10 CKO retinae revealed that BrdU-positive cells were
forming the rosette outer cellular layers (Fig 5B) whereas OTX2 positive photoreceptors were
forming the rosette inner cellular layers (Fig 5D). However, in the Adam10 CKO retinae,
OTX2-positive photoreceptors were also identified as highly disorganized cells present at the
apical and basal surface as well as cells randomly scattered throughout the retina (Fig 5D). The
ISL1-positive cells did not associate with rosettes and appeared to be randomly distributed
throughout the Adam10 CKO (Fig 5D). It was shown previously that both N-cadherin and βcatenin are indispensable for the formation of retinal laminae [43, 44], thus we wanted to determine if N-cadherin and β-catenin expression had been altered in the Adam10 CKO retinae. In
the control retinae both N-cadherin and β-catenin (Fig 5E–5G) were expressed throughout the
retina especially in the cells forming apical and basal surfaces consistent with previous reports
[44]. In the Adam10 CKO retinae both N-cadherin (Fig 5F) and β-catenin (Fig 5H) were highly
expressed in cells forming the rosette lumens whereas cells forming apical and basal surfaces
intermittently expressed both N-cadherin and β-catenin. Next, we wanted to determine if cell
death was contributing to the formation of rosettes. In E16.5 control retinae, we identified a
very few TUNEL-positive cells (Fig 5I) whereas in Adam10 CKO the TUNEL-positive cells
were scattered throughout all layers of the retinae (Fig 5J). Although a significantly greater
(P = 0.003; n = 3) percentage of TUNEL-positive cells were identified in Adam10 CKO retinae
(Fig 5H) when compared to controls, the overall percentage of TUNEL-positive cells was very
small (<5%) in both the WT and Adam10 CKO retinae (Fig 5K). Consistent with this, the
overall number of DAPI positive cells did not significantly differ (P = 0.19; n = 3) between the
two genotypes (Fig 5L).

ADAM10 regulates NOTCH signaling
Next, we set out to determine if disrupted NOTCH1 signaling contributed to the retinal phenotypes identified in Adam10 CKO retinae. Immunostaining of E13.5 control retinae revealed
that NOTCH1 positive immunostaining was restricted to the neuroblastic layer (Fig 6A). By
contrast in E13.5 Adam10 CKO retinae very few cells within the central retina stained positive
for NOTCH1, although towards the retinal periphery highly disorganized NOTCH1 positive
cells were evident (Fig 6B). Quantification analysis confirmed a significantly (P = 0.001; n = 3)
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Fig 4. Retinal neurogenesis at E13.5 in control and Adam10 CKO mice. In the control retinae (A) the EdUpositive cells were highly organized along the apical surface with no EdU-positive cells present at the basal
surface. By contrast, in the Adam10 CKO eyes (B) within the central retinae a few highly disorganized EdUpositive cells were identified. Quantification analysis (C) revealed in control retinae 33.50 ± 0.61% (gray bar)
and in Adam10 CKO retinae 20.01± 2.5% (white bar) EdU-positive cells indicating a significantly lower
(**P = 0.019; n = 3) percentage of EdU-positive cells in the Adam10 CKO retinae. In the control retinae (D),
sparse OTX2-positive immunostaining was identified in cells along the apical surface. In Adam10 CKO retinae
(E), OTX2-positive cells were present in all retinal layers. Quantification analysis (F) revealed in control retinae
7.95 ± 0.9% (gray bar) and in Adam10 CKO retinae 27.1 ± 2.8% (white bar) OTX2- positive cells indicating a
significantly greater (**P = 0.003; n = 3) percentage of OTX2-positive cells in Adam10 CKO retinae. In the
control retinae (G), ISL1-positive cells were identified within the basal layer whereas in Adam10 CKO retinae
(H) ISL1-positive cells were highly disorganized and present in all retinal layers. Quantification analysis (I)
revealed in the control retinae 23.4 ± 3.2% (gray bar) and in Adam10 CKO retinae 50.1 ± 1.3% (white bar)
ISL1-positive cells indicating a significantly greater (**P = 0.004; n = 3) percentage of ISL1-positive cells in
the Adam10 CKO retinae. In both the control (J) and Adam10 CKO retinae (K), the OTX2-positive and
ISL1-positive cells did not co-stain for EdU. DAPI staining of the control and Adam10 CKO retinae are shown
in (L) and (M) respectively. Bars in (C), (F), and (I) represent mean values ± SEM. AP = apical surface.
BA = basal surface. Scale bar = 50 μm.
doi:10.1371/journal.pone.0156184.g004
PLOS ONE | DOI:10.1371/journal.pone.0156184 May 25, 2016

10 / 18

ADAM10 Regulates NOTCH Signaling during Early Retinal Development

Fig 5. Characterization of rosettes in E16.5 Adam10 CKO retinae. In controls (A) BrdU-positive cells were
identified in the neuroblastic layer. In Adam10 CKO retinae, BrdU-positive cells were identified in the outer
cell layer of rosettes (B, arrows). In controls (C) immunostaining for OTX2 (green) and ISL1 (red) marked
early photoreceptor cells at the apical surface and ganglion cells at the basal surface. In Adam10 CKO retinae
(D) the OTX2-positive cells (D, green) formed rosette lumens (D, white arrow), although OTX2-positive cells
were also present at the apical and basal surfaces (green arrows in D). ISL1-positive cells (D, red) did not
associate with rosettes and were scattered through the entire retina. In control retinae, N-cadherin (E) and β-
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catenin (G) were expressed in all retinal cells although the highest expression was in the cells forming the
apical surface (white arrows in E and G). In Adam10 CKO retinae cells forming the rosette lumens were highly
expressing N-cadherin and β-catenin (white arrows F and H); cells at the apical and basal surface were
intermittently expressing N-cadherin (green arrows in F) and β-catenin (red arrows in H). Very few TUNELpositive cells were identified in the control (I) and Adam10 CKO (J) retinae. Quantification analysis (K)
identified in the controls 0.4 ± 0.01% (gray bar) and in Adam10 CKO 4.69 ± 0.11% (white bar) TUNEL-positive
cells indicated a significantly greater (*P = 0.003; n = 3) percentage of TUNEL-positive cells in the Adam10
CKO retinae. Quantification analysis (L) identified 2476 ± 173 (gray bar) DAPI-positive cells in controls and
2096 ± 167 (white bar) DAPI-positive cells in Adam10 CKO retinae indicating that the overall number of retinal
cells did not significantly differ (P = 0.19; n = 3) between the two genotypes. Bars in (K) and (L) represent
mean values ± SEM. Significance was established following analysis with Student’s t-test and P<0.05 was
considered significant. In all panels, nuclei were stained with DAPI. AP = apical surface. BA = basal surface.
n.s. = not significant. Scale bar = 50 μm.
doi:10.1371/journal.pone.0156184.g005

lower percentage of NOTCH1 positive cells in E13.5 Adam10 CKO retinae when compared to
the age-matched controls (Fig 6C). Immunostaining for HES1, which is a NOTCH1 downstream target [15], revealed a very few HES1-immunopositive cells within the central E13.5
Adam10 CKO retinae that appeared highly disorganized (Fig 6D). However, at the retinal
periphery HES1 positive cells were identified restricted to the neuroblastic layer (not shown).
Quantification analysis confirmed a significantly (P = 0.0004; n = 3) lower percentage of
HES1-positive in E13.5 Adam10 CKO retinae when compared to the age-matched controls.
In order to determine if disrupted NOTCH1 signaling is directly caused by a functional loss
of ADAM10, we utilized a genetic approach. We focused on establishing if overexpression of
the NOTCH1-intracellular domain (N1-ICD) can rescue aberrant morphogenesis and/or neurogenesis identified in Adam10 CKO retinae. We crossed Adam10 CKO mice to Gt(ROSA)
26Sor tm1(NOTCH1)Dam/J mice and generated mice with genotypes Six3-Cre;Adam10 CKO;
RosaN1-IC/+ (Adam10 CKO;N1-ICD) wherein the same retinal cells Six3-driven CRE recombinase activity deleted Adam10 exon 3 and overexpressed N1-ICD; mice with Six3-Cre;
RosaN1-IC/+ (N1-ICD) genotypes, where Six3-CRE-mediated constitutive retinal activation of
N1ICD, were used as controls (Fig 6G). At E13.5 cells, both N1-ICD retinae (Fig 6H) and
Adam10 CKO;N1-ICD retinae (Fig 6I), were highly organized along the apical-basal axis with
well-defined apical and basal surfaces. EdU incorporation revealed that in both N1-ICD retinae
(Fig 6J) and Adam10 CKO; N1-ICD retinae (Fig 6K) proliferative cells were present in all retinal layers suggesting that all retinal cells in these mice were maintained in the progenitor state.
The percentage of EdU positive cells did not significantly differ between the genotypes (Fig
6L). To explore this further, we immunostained E13.5 N1-ICD retinae and Adam10 CKO;
N1-ICD retinae for OTX2 and ISL1 as early photoreceptor and ganglion cell markers respectively. Within the central region of both N1-ICD retinae (S4A Fig) and Adam10 CKO; N1-ICD
(S4B Fig) we did not identify any OTX2-positive or ISL1-positive cells. However, at the retinal
periphery very few OTX2-positive (<1%) and ISL1-positive cells (<3%) were identified in
both N1-ICD (S4C Fig) and Adam10 CKO; N1-ICD retinae (S4D Fig). Quantification analysis
did not identify a significant difference between N1-ICD and Adam10 CKO;N1-ICD retinae in
the percentage of OTX2-positive and ISL1-positive cells (S4E and S4F Fig).

Discussion
In this study, we show that ADAM10 is indispensable for retinal neurogenesis as well as the
formation of retinal laminae. The rescue of aberrant retinal phenotypes in ADAM10-deficient
retinae by overexpression of the N1-ICD provides in vivo genetic evidence that ADAM10 is a
key regulator of NOTCH1 signaling. In mice during early retinal development NOTCH1
maintains retinal cells in the undifferentiated progenitor state, but it also has a role in repressing photoreceptor cell fate [10, 11]. As such the role of NOTCH1 signaling has been proposed
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Fig 6. Overexpression of N1-ICD in Adam10 CKO retinae rescues aberrant retinal morphogenesis and
neurogenesis. In controls (A) NOTCH1-positive cells were restricted to the neuroblastic layer. In Adam10 CKO
retinae, within the central retinae only a very few NOTCH1-positive cells were identified associated with rosettes
(B, arrow) although towards the retinal periphery NOTCH1-positive cells were identified restricted to the
neuroblastic layer (B, arrowhead). Quantification analysis (C) identified in controls 42 ± 1.2% (gray bar) and in
Adam10 CKO 22.79 ± 0.11% (white bar) NOTCH1-positive cells indicating a significantly fewer (**P = 0.001;
n = 3) percentage of NOTCH1-positive cells in Adam10 CKO retinae when compared to the controls. In controls
HES1, immunostaining was restricted to the neuroblastic layer (D) whereas in Adam10 CKO retinae a very few
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HES1-positive cells were identified within the central retinae and HES1-positve cells appeared disorganized (E).
Quantification analysis (F) identified in controls 34 ± 0.01% (gray bar) and in Adam10 CKO retinae 4.7 ± 0.2%
(white bar) HES1-positive cells indicating a significantly fewer (**P = 0.0004; n = 3) percentage of HES1-positive
cells in Adam10 CKO retinae when compared to controls. (G) Adam10 CKO mice were crossed to RosaN1-IC
(N1-ICD) mice harboring a Neo/STOP cassette flanked by loxP sites upstream of a sequence encoding the
intracellular domain of the NOTCH1 gene thereby generating Adam10 CKO; N1-ICD mice that exhibit constitutive
expression of N1-ICD in the same retinal cells in which Six3-CRE led to ablation of Adam10. H&E staining
revealed in N1-ICD mice (H) and Adam10 CKO;N1-IC mice (I) highly organized retinae. In N1-ICD retinae (J) and
Adam10 CKO;N1-IC retinae (K) EdU-positive cells were present in all retinal layers. Quantification analysis (L)
revealed in N1-ICD retinae 41.99 ± 2.78% (gray bar) and in Adam10 CKO retinae 44.15 ± 3.76% (white bar) EdUpositive cells indicating that the percentage of EdU positive retinal cells did not significantly differ (P = 0.24; n = 3).
Bars in (C), (F), and (L) represent mean values ± SEM. Significance was established with the Student’s t-test and
P<0.05 was considered significant. AP = apical surface. BA = basal surface. Scale bars = 50 μm.
doi:10.1371/journal.pone.0156184.g006

to have a key role in assuring the sufficient number of progenitor cells necessary for the development of all retinal cell types [10, 11]. Results from this study showed that ADAM10 deficiency decreased the pool of retinal progenitor cells and increased the production of early
photoreceptors further supporting the idea that ADAM10 is a regulator of NOTCH1 signaling.
However, our results also show that ADAM10 retinal deficiency increased the production of
ganglion cells, a phenotype not identified in mice with NOTCH1-deficient retinae [10, 11].
ADAM10 ablation in the developing retina phenocopies aberrant retinal neurogenesis in mice
with retinae deficient for both NOTCH1 and NOTCH3 [45] as well as in mice with retinae
deficient for RPBJ [12]. While it is well established that NOTCH1 is a regulator of the progenitor cell pool and represses photoreceptor fate, recent studies have shown both NOTCH3 and
NOTCH1 contribute to the repression of ganglion cell fate [45]. Furthermore both NOTCH1
and NOTCH3 signal through RBPJ as a common downstream target [12]. Therefore, it was
hypothesized that NOTCH1+NOTCH3>RBPJ repress retinal ganglion cell fate. We propose
that ADAM10 is a common NOTCH signaling regulator by facilitating the cleavage of both
NOTCH1 and NOTCH3 which in turn facilitates maintenance of the progenitor cell pool and
repression of both photoreceptors and ganglion cells. In support of this hypothesis are recent
reports showing that in cell culture ADAM10 cleaves NOTCH3 via a similar mechanism as
NOTCH1 [46]. Additionally, during retinal development expression of NOTCH1 and
NOTCH3 spatially and temporally coincide [47]. However, further studies are needed to
unequivocally establish if ADAM10 mediates the cleavage of both NOTCH1 and NOTCH3
during early retinal neurogenesis.
In addition to aberrant neurogenesis, ADAM10 retinal ablation also results in severely disrupted formation of retinal laminae. Prior to differentiation, RPCs are positioned along the apical-basal axis and are attached to both the apical and basal surfaces [48, 49]. As RPCs start to
differentiate, they undergo detachment allowing the cells to migrate to the appropriate retinal
layer thereby establishing the retinal laminae and neuronal circuitry required for vision [48, 49].
Our results show that ADAM10 retinal deficiency results in the formation of rosettes similar to
the rosettes reported for mice with disrupted retinal NOTCH1 signaling [9–15]. It was shown
that RBPJ retinal deficiency causes discontinuous expression of β-catenin resulting in the formation of rosettes; ectopic overexpression of β-catenin in RBPJ-deficient retinae rescued the rosette
formation without rescuing neurogenesis defects [13]. How disrupted retinal NOTCH1 signaling alters β-catenin expression still remains unclear. Active β-catenin is a downstream effector
of Wnt signaling [50], but active β-catenin is also bound to N-cadherin at the cell membranes
[51, 52]. A functional deficiency of either N-cadherin or β-catenin disrupts the formation of retinal laminae without disrupted neurogenesis [43, 44, 53, 54]. However, it was shown previously
that ADAM10 mediates the cleavage of N-cadherin and as such regulates the release of active βcatenin into the cytoplasmic pool [51]. At this point, it is unclear if the rosetting phenotypes
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observed in ADAM10-deficient retinae are solely caused by the disrupted NOTCH1 signaling
or if disrupted ADAM10-mediated cleavage of N-cadherin also contributes to the aberrant retinal morphogenesis. The rescue of aberrant retinal morphology in ADAM10-deficeint retinae by
overexpression of N1-ICD supports the idea that the failure in the formation of laminae in the
ADAM10-deficeint retinae is solely caused by disrupted NOTCH1 signaling. However, we cannot exclude the possibility that ADAM10 may be regulating the cleavage of N-cadherin as a
downstream event following cleavage of the NOTCH1 receptor.
While this study establishes ADAM10 as indispensable for the early retinal development, the
role of ADAM17 still remains unclear. Our results show that ADAM10 and ADAM17 exhibit
an overlapping spatiotemporal expression pattern in the developing mouse retinae consistent
with the expression of ADAM10 and ADAM17 previously reported for the developing chick
retinae [34]. However, it should be pointed out that another study using a different antibody
identified that in mice, the retinal expression of ADAM17 starts at P7 [55]. Furthermore, the
same study revealed that in the adult (P175) mouse retinae ADAM17 expression is restricted to
the ganglion cell layer, the inner and outer edge of the inner nuclear layer [55]. This discrepancy
may have been caused by the variable specificity of the antibodies used as well as different time
points selected for the analysis. Nonetheless, our findings unequivocally indicate that ADAM17
is dispensable for retinal development. In the developing chick retina, in addition to ADAM10,
ADAM17 exhibits similar spatiotemporal expression pattern with ADAM9, ADAM12,
ADAM13, ADAM22, and ADAM23 [34]. Except for ADAM9, that has been shown to have a
role in the development of retinal vasculature and homeostasis [56, 57], the roles of other
ADAM proteins during retinal development and homeostasis are unknown providing no information if ADAM17 may have functional overlaps with other ADAM proteins. Studies focusing
on the role of ADAM17 as a regulator of retinal homeostasis are currently in progress.
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